Epizyme collaborates with Foundation Medicine for Phase II trial of tazemetostat

US-based clinical-stage biopharmaceutical company Epizyme has collaborated with genomic analysis diagnostics firm Foundation Medicine to support patient identification and enrolment for its ongoing Phase II clinical trial of tazemetostat in patients …
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news